Leide Biosciences Co., Ltd.

mIGRA^TM represents a groundbreaking advancement as the world's premier portable mobile tuberculosis testing system, built upon the IGRA principle and employing immunofluorescence chromatography. This innovative technology offers rapid, efficient, and professional testing capabilities, delivering an all-in-one solution for IGRA tuberculosis testing. The mIGRA^TM system seamlessly integrates essential components, including sampling, stimulation, incubation, and separation, ensuring a comprehensive and streamlined testing process.

① Thoughtful Design

The product boasts a portable design and an integrated solution, catering to diverse usage scenarios, ensuring convenience and adaptability.

② Exceptional Performance

With a high sensitivity range of 85%-95% and a high specificity range of 93%-99%, the product remains unaffected by interference from the BCG vaccine and most non-tuberculous mycobacteria. It consistently delivers accurate and reliable results.

③ User-Friendly Operation

The product operates as a Point-of-Care Testing (POCT) platform, enabling rapid detection with results available within 15 minutes. It eliminates the need for repeated calibration and incorporates automatic result interpretation, simplifying the testing process.

④ Cost-Effective Solution

Featuring room temperature storage and transportation capabilities, the product significantly reduces storage costs. Furthermore, its user-friendly operation minimizes labor costs, making it an economically viable option.

Ideal for on-site testing during tuberculosis outbreaks, cluster outbreaks, and unexpected public health emergencies, the product offers unmatched suitability. It excels in screening tuberculosis within key population groups and conducting emergency contact tracing swiftly and effectively. Its capabilities are specifically tailored to meet the urgent demands of such scenarios, ensuring timely interventions and efficient management of tuberculosis cases.

Movable LTBI detection system